Advocacy Actions
Call for Comments: NIFDC notice on Research and Technical Guideline for Anti-freckle and whiting cosmetics products and ingredient
on 31st March, the cosmetics working group submitted the consolidated comments on Research and Technical Guideline for Anti-freckle and whiting cosmetics products and ingredient published by NIFDC.
Read moreMeeting with Shanghai Medical Products Administration and European Cosmetics Association
On 27th March 2023, the cosmetics working group representatives attended the meeting with Shanghai Medical Products Administration and European Cosmetics Association.
Read moreComment to SAMR on Notice of Public Consultation on the Guidelines for Enforcement of Absolutist Terms in Advertising (Draft for Comments)
The Agriculture, Food and Beverage Working Group, Food for Special Medical Purpose, Dairy Industry and Pediatric Nutrition Sub-working Groups, Compliance and Business Ethics Working Group, Cosmetics Working Group, Fashion and Leather Desk submitted collated comments to State Administration for Marketing Regulation on The Agriculture, Food and Beverage Working Group, Food for Special Medical Purpose, Dairy Industry and Pediatric Nutrition Sub-working Groups submitted collated comments to State Administration for Marketing Regulation on Regulations (SAMR) on the Supervision and Management of Enterprises' Implementation of the Main Responsibility for Food Safety (Draft for Comments).
Read moreMeeting with Bureau of Import and Export Food Safety, General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ)
On 5th December, EUCCC Cosmetic Working Group and AFB Working Group paid a visit to Bureau of Import and Export Food Safety, General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ).
Read moreMeeting with CAFFCI
On 1 December, CAFFCI organized a meeting for the industry representatives with Qi Liubin, Director of Cosmetic Division, Department of Drug and Cosmetic Registration.
Read moreDepartment of Legal Affairs Call for Comments on Draft of Cosmetic Supervision and Administration Regulation (CSAR)
EUCCC Cosmetic Working Group met the deadline set by Department of Legal Affairs on call for comments on draft of Cosmetic Supervision and Administration Regulation (CSAR) on 24 November.
Read moreMeeting with Department of Legal Affairs, CFDA on CSAR draft for comments
On 21 November, Department of Legal Affairs of CFDA called for a consultation meeting with participation of associations, chambers and representatives from leading domestic and foreign cosmetic companies, on the draft of Cosmetic Supervision and Administration Regulation (CSAR).
Read morePresentation on CHMR by CAG professor at Cosmetics WG Meeting
Prof. Yang is one of the key consultants invited by CFDA Department of Legal Affairs on CHRM revision draft.
Read moreDG SANCO Meeting with China Food and Drug Administration
DG SANCO, CFDA, Chinese experts and EU experts in the cosmetics industry had a whole day communication and exchange on the regulatory and technical issues on 2 September. It was a very open discussion, and very well participated. All parties welcomed such a good communication opportunity, and agreed that it was a very healthy way to cooperate for both regulators and experts in China and EU side. In the morning session, EU experts introduced Animal Testing Bans in the EU and Status of Alternative methods, detailed introduction of the Safety Assessment Procedure of Finished Products and Efficacy Assessment Guideline on Cosmetics. In the afternoon session, CAFCCI expert and Shi Yue from IMPLAD introduced the 8783 version used ingredients list and responded to our reported suspicious missing ingredients by EUCCC Cosmetics Working Group. EU experts introduced the principles and Practical Aspects of Labelling of Cosmetics in the EU. Director Qi Liubin introduced the process of new ingredients registration, domestic non functional on line notification and imported non functional decentralization.
Lobby Letter to China CFDA – Missing Ingredients
On 13rd August 2014, the Cosmetic Working Group submitted a report to the China Food and Drug Administration regarding the suspicious missing ingredients based on the published 8783 version used ingredients list.
Read more